Search
-
Ipsos launches a voluntary public takeover offer for infas to acquire the industry leader in German public sector research
Voluntary public takeover offer
-
Flair Morocco 2024: Achievement and Accelerations
In this first edition of Flair Morocco, our local experts share their perspectives on themes including emerged middle classes, inflation, and global megatrends.
-
Bringing Healthcare Segmentations to Life: The Dawn of the GenAI-Powered Persona
Enter the age of generative AI, ushering in a new era of possibility with the advent of the persona bot – a tool with the potential to revolutionise how pharmaceutical companies activate and leverage segmentation data.
-
Launch of Ipsos PersonaBot, a groundbreaking AI-powered solution to enhance segmentation research
Ipsos has launched Ipsos PersonaBot. This AI-powered tool, powered by Ipsos Facto, allows organizations to engage in conversations with personas representing their target audience. Ipsos PersonaBot is available for both consumer and healthcare sectors.
-
A general sentiment of being well protected, coupled with greater expectations regarding insurance coverage
New Ipsos survey conducted for BNP Paribas Cardif of 21,000 people in 21 countries on 3 continents (Europe, South America and Asia) to assess people's need for protection, analyse changes in behaviour and people's expectations regarding insurance.
-
Global Attitudes to Refugees: a 52-country survey from Ipsos and UNHCR
A new 52-country survey from Ipsos and UNHCR for World Refugee Day 2024 reveals enduring public support for refugees, alongside stark variations in attitudes.
-
A Dose of Digital: Can Pharma Make DTx a Healthy Business?
Digital therapeutics (DTx) are emerging as a potential game-changer in healthcare, offering evidence-based digital interventions to help prevent, manage, or treat specific conditions.